Opioids Market Report

Global Opioids Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：228
  • REPORT CODE：GMM826405
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Opioids market report explains the definition, types, applications, major countries, and major players of the Opioids market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer Inc

    • Purdue Pharma LP

    • Sun Pharmaceutical Industries Limited

    • West-Ward Pharmaceuticals Corporation

    • Allergan

    • Janssen Pharmaceuticals Inc

    • Egalet Corporation

    By Type:

    • Immediate-Release/Short-Acting Opioid

    • Extended-Release/Long-Acting Opioid

    By End-User:

    • Pain Relief

    • Anesthesia

    • Cough Suppression

    • Diarrhea Suppression

    • Deaddiction

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Opioids Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Opioids Outlook to 2028- Original Forecasts

    • 2.2 Opioids Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Opioids Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Opioids Market- Recent Developments

    • 6.1 Opioids Market News and Developments

    • 6.2 Opioids Market Deals Landscape

    7 Opioids Raw Materials and Cost Structure Analysis

    • 7.1 Opioids Key Raw Materials

    • 7.2 Opioids Price Trend of Key Raw Materials

    • 7.3 Opioids Key Suppliers of Raw Materials

    • 7.4 Opioids Market Concentration Rate of Raw Materials

    • 7.5 Opioids Cost Structure Analysis

      • 7.5.1 Opioids Raw Materials Analysis

      • 7.5.2 Opioids Labor Cost Analysis

      • 7.5.3 Opioids Manufacturing Expenses Analysis

    8 Global Opioids Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Opioids Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Opioids Export by Region (Top 10 Countries) (2017-2028)

    9 Global Opioids Market Outlook by Types and Applications to 2022

    • 9.1 Global Opioids Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immediate-Release/Short-Acting Opioid Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Extended-Release/Long-Acting Opioid Consumption and Growth Rate (2017-2022)

    • 9.2 Global Opioids Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pain Relief Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Anesthesia Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cough Suppression Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Diarrhea Suppression Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Deaddiction Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Opioids Market Analysis and Outlook till 2022

    • 10.1 Global Opioids Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Opioids Consumption (2017-2022)

      • 10.2.2 Canada Opioids Consumption (2017-2022)

      • 10.2.3 Mexico Opioids Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Opioids Consumption (2017-2022)

      • 10.3.2 UK Opioids Consumption (2017-2022)

      • 10.3.3 Spain Opioids Consumption (2017-2022)

      • 10.3.4 Belgium Opioids Consumption (2017-2022)

      • 10.3.5 France Opioids Consumption (2017-2022)

      • 10.3.6 Italy Opioids Consumption (2017-2022)

      • 10.3.7 Denmark Opioids Consumption (2017-2022)

      • 10.3.8 Finland Opioids Consumption (2017-2022)

      • 10.3.9 Norway Opioids Consumption (2017-2022)

      • 10.3.10 Sweden Opioids Consumption (2017-2022)

      • 10.3.11 Poland Opioids Consumption (2017-2022)

      • 10.3.12 Russia Opioids Consumption (2017-2022)

      • 10.3.13 Turkey Opioids Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Opioids Consumption (2017-2022)

      • 10.4.2 Japan Opioids Consumption (2017-2022)

      • 10.4.3 India Opioids Consumption (2017-2022)

      • 10.4.4 South Korea Opioids Consumption (2017-2022)

      • 10.4.5 Pakistan Opioids Consumption (2017-2022)

      • 10.4.6 Bangladesh Opioids Consumption (2017-2022)

      • 10.4.7 Indonesia Opioids Consumption (2017-2022)

      • 10.4.8 Thailand Opioids Consumption (2017-2022)

      • 10.4.9 Singapore Opioids Consumption (2017-2022)

      • 10.4.10 Malaysia Opioids Consumption (2017-2022)

      • 10.4.11 Philippines Opioids Consumption (2017-2022)

      • 10.4.12 Vietnam Opioids Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Opioids Consumption (2017-2022)

      • 10.5.2 Colombia Opioids Consumption (2017-2022)

      • 10.5.3 Chile Opioids Consumption (2017-2022)

      • 10.5.4 Argentina Opioids Consumption (2017-2022)

      • 10.5.5 Venezuela Opioids Consumption (2017-2022)

      • 10.5.6 Peru Opioids Consumption (2017-2022)

      • 10.5.7 Puerto Rico Opioids Consumption (2017-2022)

      • 10.5.8 Ecuador Opioids Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Opioids Consumption (2017-2022)

      • 10.6.2 Kuwait Opioids Consumption (2017-2022)

      • 10.6.3 Oman Opioids Consumption (2017-2022)

      • 10.6.4 Qatar Opioids Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Opioids Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Opioids Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Opioids Consumption (2017-2022)

      • 10.7.2 South Africa Opioids Consumption (2017-2022)

      • 10.7.3 Egypt Opioids Consumption (2017-2022)

      • 10.7.4 Algeria Opioids Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Opioids Consumption (2017-2022)

      • 10.8.2 New Zealand Opioids Consumption (2017-2022)

    11 Global Opioids Competitive Analysis

    • 11.1 Pfizer Inc

      • 11.1.1 Pfizer Inc Company Details

      • 11.1.2 Pfizer Inc Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Inc Opioids Main Business and Markets Served

      • 11.1.4 Pfizer Inc Opioids Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Purdue Pharma LP

      • 11.2.1 Purdue Pharma LP Company Details

      • 11.2.2 Purdue Pharma LP Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Purdue Pharma LP Opioids Main Business and Markets Served

      • 11.2.4 Purdue Pharma LP Opioids Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Sun Pharmaceutical Industries Limited

      • 11.3.1 Sun Pharmaceutical Industries Limited Company Details

      • 11.3.2 Sun Pharmaceutical Industries Limited Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Sun Pharmaceutical Industries Limited Opioids Main Business and Markets Served

      • 11.3.4 Sun Pharmaceutical Industries Limited Opioids Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 West-Ward Pharmaceuticals Corporation

      • 11.4.1 West-Ward Pharmaceuticals Corporation Company Details

      • 11.4.2 West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 West-Ward Pharmaceuticals Corporation Opioids Main Business and Markets Served

      • 11.4.4 West-Ward Pharmaceuticals Corporation Opioids Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Allergan

      • 11.5.1 Allergan Company Details

      • 11.5.2 Allergan Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Allergan Opioids Main Business and Markets Served

      • 11.5.4 Allergan Opioids Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Janssen Pharmaceuticals Inc

      • 11.6.1 Janssen Pharmaceuticals Inc Company Details

      • 11.6.2 Janssen Pharmaceuticals Inc Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Janssen Pharmaceuticals Inc Opioids Main Business and Markets Served

      • 11.6.4 Janssen Pharmaceuticals Inc Opioids Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Egalet Corporation

      • 11.7.1 Egalet Corporation Company Details

      • 11.7.2 Egalet Corporation Opioids Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Egalet Corporation Opioids Main Business and Markets Served

      • 11.7.4 Egalet Corporation Opioids Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Opioids Market Outlook by Types and Applications to 2028

    • 12.1 Global Opioids Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Immediate-Release/Short-Acting Opioid Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Extended-Release/Long-Acting Opioid Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Opioids Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pain Relief Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Cough Suppression Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Diarrhea Suppression Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Deaddiction Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Opioids Market Analysis and Outlook to 2028

    • 13.1 Global Opioids Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Opioids Consumption Forecast (2022-2028)

      • 13.2.2 Canada Opioids Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Opioids Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Opioids Consumption Forecast (2022-2028)

      • 13.3.2 UK Opioids Consumption Forecast (2022-2028)

      • 13.3.3 Spain Opioids Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Opioids Consumption Forecast (2022-2028)

      • 13.3.5 France Opioids Consumption Forecast (2022-2028)

      • 13.3.6 Italy Opioids Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Opioids Consumption Forecast (2022-2028)

      • 13.3.8 Finland Opioids Consumption Forecast (2022-2028)

      • 13.3.9 Norway Opioids Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Opioids Consumption Forecast (2022-2028)

      • 13.3.11 Poland Opioids Consumption Forecast (2022-2028)

      • 13.3.12 Russia Opioids Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Opioids Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Opioids Consumption Forecast (2022-2028)

      • 13.4.2 Japan Opioids Consumption Forecast (2022-2028)

      • 13.4.3 India Opioids Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Opioids Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Opioids Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Opioids Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Opioids Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Opioids Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Opioids Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Opioids Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Opioids Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Opioids Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Opioids Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Opioids Consumption Forecast (2022-2028)

      • 13.5.3 Chile Opioids Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Opioids Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Opioids Consumption Forecast (2022-2028)

      • 13.5.6 Peru Opioids Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Opioids Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Opioids Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Opioids Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Opioids Consumption Forecast (2022-2028)

      • 13.6.3 Oman Opioids Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Opioids Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Opioids Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Opioids Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Opioids Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Opioids Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Opioids Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Opioids Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Opioids Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Opioids Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Opioids

    • Figure of Opioids Picture

    • Table Global Opioids Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Opioids Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Immediate-Release/Short-Acting Opioid Consumption and Growth Rate (2017-2022)

    • Figure Global Extended-Release/Long-Acting Opioid Consumption and Growth Rate (2017-2022)

    • Figure Global Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Global Anesthesia Consumption and Growth Rate (2017-2022)

    • Figure Global Cough Suppression Consumption and Growth Rate (2017-2022)

    • Figure Global Diarrhea Suppression Consumption and Growth Rate (2017-2022)

    • Figure Global Deaddiction Consumption and Growth Rate (2017-2022)

    • Figure Global Opioids Consumption by Country (2017-2022)

    • Table North America Opioids Consumption by Country (2017-2022)

    • Figure United States Opioids Consumption and Growth Rate (2017-2022)

    • Figure Canada Opioids Consumption and Growth Rate (2017-2022)

    • Figure Mexico Opioids Consumption and Growth Rate (2017-2022)

    • Table Europe Opioids Consumption by Country (2017-2022)

    • Figure Germany Opioids Consumption and Growth Rate (2017-2022)

    • Figure UK Opioids Consumption and Growth Rate (2017-2022)

    • Figure Spain Opioids Consumption and Growth Rate (2017-2022)

    • Figure Belgium Opioids Consumption and Growth Rate (2017-2022)

    • Figure France Opioids Consumption and Growth Rate (2017-2022)

    • Figure Italy Opioids Consumption and Growth Rate (2017-2022)

    • Figure Denmark Opioids Consumption and Growth Rate (2017-2022)

    • Figure Finland Opioids Consumption and Growth Rate (2017-2022)

    • Figure Norway Opioids Consumption and Growth Rate (2017-2022)

    • Figure Sweden Opioids Consumption and Growth Rate (2017-2022)

    • Figure Poland Opioids Consumption and Growth Rate (2017-2022)

    • Figure Russia Opioids Consumption and Growth Rate (2017-2022)

    • Figure Turkey Opioids Consumption and Growth Rate (2017-2022)

    • Table APAC Opioids Consumption by Country (2017-2022)

    • Figure China Opioids Consumption and Growth Rate (2017-2022)

    • Figure Japan Opioids Consumption and Growth Rate (2017-2022)

    • Figure India Opioids Consumption and Growth Rate (2017-2022)

    • Figure South Korea Opioids Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Opioids Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Opioids Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Opioids Consumption and Growth Rate (2017-2022)

    • Figure Thailand Opioids Consumption and Growth Rate (2017-2022)

    • Figure Singapore Opioids Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Opioids Consumption and Growth Rate (2017-2022)

    • Figure Philippines Opioids Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Opioids Consumption and Growth Rate (2017-2022)

    • Table South America Opioids Consumption by Country (2017-2022)

    • Figure Brazil Opioids Consumption and Growth Rate (2017-2022)

    • Figure Colombia Opioids Consumption and Growth Rate (2017-2022)

    • Figure Chile Opioids Consumption and Growth Rate (2017-2022)

    • Figure Argentina Opioids Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Opioids Consumption and Growth Rate (2017-2022)

    • Figure Peru Opioids Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Opioids Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Opioids Consumption and Growth Rate (2017-2022)

    • Table GCC Opioids Consumption by Country (2017-2022)

    • Figure Bahrain Opioids Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Opioids Consumption and Growth Rate (2017-2022)

    • Figure Oman Opioids Consumption and Growth Rate (2017-2022)

    • Figure Qatar Opioids Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Opioids Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Opioids Consumption and Growth Rate (2017-2022)

    • Table Africa Opioids Consumption by Country (2017-2022)

    • Figure Nigeria Opioids Consumption and Growth Rate (2017-2022)

    • Figure South Africa Opioids Consumption and Growth Rate (2017-2022)

    • Figure Egypt Opioids Consumption and Growth Rate (2017-2022)

    • Figure Algeria Opioids Consumption and Growth Rate (2017-2022)

    • Table Oceania Opioids Consumption by Country (2017-2022)

    • Figure Australia Opioids Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Opioids Consumption and Growth Rate (2017-2022)

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Opioids Main Business and Markets Served

    • Table Pfizer Inc Opioids Product Portfolio

    • Table Purdue Pharma LP Company Details

    • Table Purdue Pharma LP Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma LP Opioids Main Business and Markets Served

    • Table Purdue Pharma LP Opioids Product Portfolio

    • Table Sun Pharmaceutical Industries Limited Company Details

    • Table Sun Pharmaceutical Industries Limited Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Limited Opioids Main Business and Markets Served

    • Table Sun Pharmaceutical Industries Limited Opioids Product Portfolio

    • Table West-Ward Pharmaceuticals Corporation Company Details

    • Table West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table West-Ward Pharmaceuticals Corporation Opioids Main Business and Markets Served

    • Table West-Ward Pharmaceuticals Corporation Opioids Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Opioids Main Business and Markets Served

    • Table Allergan Opioids Product Portfolio

    • Table Janssen Pharmaceuticals Inc Company Details

    • Table Janssen Pharmaceuticals Inc Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Inc Opioids Main Business and Markets Served

    • Table Janssen Pharmaceuticals Inc Opioids Product Portfolio

    • Table Egalet Corporation Company Details

    • Table Egalet Corporation Opioids Sales, Price, Value and Gross Profit (2017-2022)

    • Table Egalet Corporation Opioids Main Business and Markets Served

    • Table Egalet Corporation Opioids Product Portfolio

    • Figure Global Immediate-Release/Short-Acting Opioid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extended-Release/Long-Acting Opioid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cough Suppression Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diarrhea Suppression Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deaddiction Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opioids Consumption Forecast by Country (2022-2028)

    • Table North America Opioids Consumption Forecast by Country (2022-2028)

    • Figure United States Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Opioids Consumption Forecast by Country (2022-2028)

    • Figure Germany Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Opioids Consumption Forecast by Country (2022-2028)

    • Figure China Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Opioids Consumption Forecast by Country (2022-2028)

    • Figure Brazil Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Opioids Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Opioids Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Opioids Consumption Forecast by Country (2022-2028)

    • Figure Australia Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Opioids Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US